Loading…
Dyne Therapeutics, Inc. is projected to rise to $21.36 by 2027, a +18% move from its current price of $18.16. DYN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $17.57 | $18.16 | $18.78 | +0.01% |
| May 30 | $17.33 | $18.16 | $19.04 | +0.02% |
| May 31 | $17.15 | $18.17 | $19.25 | +0.03% |
| Jun 1 | $17.00 | $18.17 | $19.42 | +0.04% |
| Jun 2 | $16.87 | $18.17 | $19.58 | +0.06% |
| Jun 3 | $16.75 | $18.17 | $19.72 | +0.07% |
| Jun 4 | $16.64 | $18.17 | $19.85 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $16.64 | $18.17 | $19.85 | +0.08% |
| Week 2 | $16.06 | $18.19 | $20.60 | +0.15% |
| Week 3 | $15.62 | $18.20 | $21.20 | +0.23% |
| Week 4 | $15.27 | $18.22 | $21.73 | +0.31% |
| Week 5 | $14.97 | $18.23 | $22.20 | +0.39% |
| Week 6 | $14.70 | $18.24 | $22.64 | +0.46% |
| Week 7 | $14.46 | $18.26 | $23.05 | +0.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Dyne Therapeutics, Inc. is a clinical-stage healthcare company focused on discovering and developing therapeutics for neuromuscular diseases in the United States.
The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics.
Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Dyne Therapeutics, Inc. (DYN) is currently priced at $17.37 and has a market capitalization of $2.87B. It is ranked #1760 in market capitalization.
The stock’s price sits near key moving averages: SMA50 at $18.25 and SMA200 at $17.15. The 30-day range spans from $13.87 to $21.76, and the stock carries a NEUTRAL technical sentiment with RSI14 at 50.
Forecasts project a rising long-term path, with the 2026 average price at $17.37 and advancing toward higher levels by 2050, where the average is $120.41 and the max reaches $243.74. The outlook shows a sequence of bullish years after 2026, with multi-year averages climbing and substantial potential upside reflected in the ROI figures.
A major floor 24.7% below — a decisive break under it would weaken the trend.
The nearest floor, 12.3% below — buyers have tended to step in here.
The nearest ceiling, 12.4% above — a clean break opens room to run.
A major ceiling 24.7% above — clearing it would confirm fresh momentum.
Key DYN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DYN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $17.72 | Buy | $17.76 | Buy |
| MA 10 | $17.51 | Buy | $17.66 | Buy |
| MA 20 | $17.67 | Buy | $17.79 | Buy |
| MA 50 | $18.25 | Sell | $17.95 | Buy |
| MA 100 | $17.67 | Buy | $17.79 | Buy |
| MA 200 | $17.22 | Buy | $17.42 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.16 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 64.64 | Neutral |
| Williams %R (14) | -11.81 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 3.12 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 88.19 | Sell |
| TRIX (15) | -0.21 | Sell |
| Awesome (5,34) | -0.60 | Sell |
| Ultimate (7,14,28) | 54.07 | Neutral |
| Momentum (10) | -0.21 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 18.05 | Buy |
| ADX (14) | 10.12 | Neutral |
| ATR (14) | 0.51 | Info |
The near-term picture is NEUTRAL, with RSI14 at 50 suggesting balanced momentum. The stock trades around the SMA50 of $18.25 and is just above the SMA200 of $17.15.
Support is listed at $15.92 and resistance at $20.41, framing a 30-day range from $13.87 to $21.76. The balance of probabilities in the short term appears to hinge on momentum around these levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $14.60 | $18.16 | $26.46 | 0% | Neutral | |
| $16.58 | $21.36 | $29.35 | +18% | Neutral | |
| $17.85 | $23.79 | $34.10 | +31% | Bullish | |
| $17.75 | $24.34 | $36.07 | +34% | Bullish | |
| $17.71 | $24.92 | $37.98 | +37% | Bullish | |
| $23.12 | $33.30 | $52.01 | +83% | Bullish | |
| $26.58 | $39.14 | $62.47 | +116% | Bullish | |
| $26.83 | $40.33 | $65.65 | +122% | Bullish | |
| $27.50 | $42.17 | $69.90 | +132% | Bullish | |
| $27.70 | $43.29 | $72.99 | +138% | Bullish | |
| $39.73 | $67.78 | $122.59 | +273% | Bullish | |
| $74.51 | $148.54 | $297.38 | +718% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $14.60 | $18.16 | $21.43 | +0.00% |
| June 2026 | $15.36 | $18.12 | $21.95 | -0.22% |
| July 2026 | $15.39 | $18.34 | $22.59 | +1.23% |
| August 2026 | $15.94 | $19.16 | $23.89 | +4.46% |
| September 2026 | $15.92 | $19.26 | $24.26 | +0.51% |
| October 2026 | $15.57 | $18.95 | $24.09 | -1.59% |
| November 2026 | $16.00 | $19.58 | $25.09 | +3.32% |
| December 2026 | $16.65 | $20.49 | $26.46 | +4.65% |
Click any year to see its month-by-month DYN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The DYN price prediction for 2026 points to an average of $18.16 (low $14.60, high $26.46) — a potential gain of 0% on today's $18.16. Price action looks broadly range-bound.
In 2027, DYN is projected to trade between $16.58 and $29.35, averaging $21.36 — a potential gain of +18% from today's $18.16. That is up +18% on the projected 2026 average. A consolidation phase looks the most probable path here.
Dyne Therapeutics, Inc.'s 2028 outlook centres on $23.79, within a $17.85 to $34.10 range. That is up +11% on the projected 2027 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2029, DYN could reach as high as $36.07, with a base case around $24.34 and support toward $17.75 — roughly +34% from $18.16. Buyers look set to stay in control over this stretch.
Expect DYN to range from $17.71 to $37.98 through 2030. The $24.92 average target implies a +37% move from current prices. That is up +2% on the projected 2029 average. Momentum favours further upside here.
The DYN price prediction for 2031 points to an average of $33.30 (low $23.12, high $52.01) — a potential gain of +83% on today's $18.16. Buyers look set to stay in control over this stretch.
In 2032, DYN is projected to trade between $26.58 and $62.47, averaging $39.14 — a potential gain of +116% from today's $18.16. That is up +18% on the projected 2031 average. Momentum favours further upside here.
Dyne Therapeutics, Inc.'s 2033 outlook centres on $40.33, within a $26.83 to $65.65 range. That is up +3% on the projected 2032 average. That marks a +122% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, DYN could reach as high as $69.90, with a base case around $42.17 and support toward $27.50 — roughly +132% from $18.16. Momentum favours further upside here.
Expect DYN to range from $27.70 to $72.99 through 2035. The $43.29 average target implies a +138% move from current prices. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The DYN price prediction for 2040 points to an average of $67.78 (low $39.73, high $122.59) — a potential gain of +273% on today's $18.16. Momentum favours further upside here.
In 2050, DYN is projected to trade between $74.51 and $297.38, averaging $148.54 — a potential gain of +718% from today's $18.16. That is up +119% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DYN today (≈ 55.066079 DYN) could be worth
$8,179.52
+$7,179.52 (+718%) by 2050 · US Dollar
Based on the average projected DYN price of $148.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DYNwould be worth at today's price.
$1,000 invested in DYN on May 27, 2025 (≈ 85.470087 DYN) would be worth
$1,552.14
+$552.14 (+55.2%) today · 1.55× · US Dollar
Based on a DYN entry price of $11.7 vs. today's $18.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.56 | $1,034.17 | +3.4% |
| 1 month ago | $18.04 | $1,006.65 | +0.7% |
| 3 months ago | $16.19 | $1,121.68 | +12.2% |
| 6 months ago | $21.9 | $829.22 | -17.1% |
| 1 year ago | $11.7 | $1,552.14 | +55.2% |
| All time (5.0y) ago | $18.62 | $975.3 | -2.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DYN forecast.
Our base-case forecast reaches $36.00 around 2032.
Implied market cap at $36.00: $5.95B
The multi-year forecast shows continued upside, with the 2030 average price projected at $22.10 and a 27.2% ROI, and bullish sentiment. Earlier increments include 2031 at $29.51 average and 69.9% ROI, continuing to climb through 2035 with 2035 average at $37.13 and 113.7% ROI.
Looking further out, the 2040 forecast indicates an average of $57.03 with a 228.3% ROI and bullish sentiment, while the 2050 forecast shows an average of $120.41 with a 593.2% ROI and bullish sentiment. These figures illustrate a long-run upside but remain subject to uncertainty and should be interpreted as estimates, not guarantees.
Tap a question to reveal the answer.
Avg $22.10, min $15.61, max $33.90, ROI 27.2%, sentiment BULLISH.
Forecasts show positive ROI across multiple years: 2027 ROI 15.3%, 2028 ROI 27.3%, 2029 ROI 27.4%, 2030 ROI 27.2%, 2031 ROI 69.9%, 2032 ROI 97.6%, 2033 ROI 101.3%, 2034 ROI 112.2%, 2035 ROI 113.7%, 2040 ROI 228.3%, and 2050 ROI 593.2%, with sentiment generally BULLISH. These are estimates and not guarantees.
Yes, the forecast max reaches $104.14 in 2040 and $243.74 in 2050, so a $100 level is within the projected range, though not guaranteed.
The 30-day range is $13.87 to $21.76; annualized volatility is 70%.
Dyne Therapeutics, Inc. Community Discussion
0Share your Dyne Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.